Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.47 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | SELE | P16581 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21775961 | 0.76 | — | — | |
| SCHEMBL22832614 | 0.74 | CYP2A6 (0.45) | CYP2A6ICAM1SELE | |
| SCHEMBL23171297 | 0.70 | CYP2A6 (0.39) | CYP2A6 | |
| SCHEMBL7250022 | 0.70 | CYP2A6 (0.45) | CYP2A6 | |
| SCHEMBL20994206 | 0.70 | CYP2A6 (0.42) | CYP2A6ICAM1SELE | |
| SCHEMBL20994213 | 0.70 | CYP2A6 (0.42) | CYP2A6ICAM1SELE | |
| SCHEMBL18032729 | 0.70 | CYP2A6 (0.42) | CYP2A6ICAM1SELE | |
| SCHEMBL20907816 | 0.70 | CYP2A6 (0.41) | CYP2A6 | |
| SCHEMBL3483221 | 0.69 | CA2 (0.47) | CYP2A6 | |
| SCHEMBL12683511 | 0.68 | CYP2A6 (0.54) | CYP2A6ICAM1SELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2566848-A1 | IMPROVED OLIGOTHIOPHENES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-03-13 | — | — | EP | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| WO-2011137487-A1 | IMPROVED OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011137487-A1 | IMPROVED OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130042918-A1 | OLIGOTHIOPHENES | NR0B2, NR2C2, NR1H2 | CYP2A6 416/4885ICAM1 4547/4885SELE 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.